StemCells Overview
- Year Founded
-
1988
- Status
-
Acquired/Merged
- Employees
-
50
- Latest Deal Type
-
M&A
- Financing Rounds
-
8
- Investments
-
2
StemCells General Information
Description
Provider of stem cell biology research services intended to address unmet medical needs through the use of novel cell-based therapeutics that hold the promise of better treatments and cures. The company offers to discover, develop, and commercialize breakthrough therapeutics and enable its clients to address unmet medical needs through novel cell-based therapeutics that promise better treatments and cures.
Contact Information
Website
www.stemcellsinc.comCorporate Office
- 39899 Balentine Drive
- Suite 200
- Newark, CA 94560
- United States
Corporate Office
- 39899 Balentine Drive
- Suite 200
- Newark, CA 94560
- United States
StemCells Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
StemCells Comparisons
Industry
Financing
Details
StemCells Competitors (25)
One of StemCells’s 25 competitors is Verge Labs, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verge Labs | Venture Capital-Backed | San Francisco, CA | ||||
| TauRx Pharmaceuticals | Private Equity-Backed | Aberdeen, United Kingdom | ||||
| Neurogene | Formerly VC-backed | New York, NY | ||||
| Asceneuron | Venture Capital-Backed | Eysins, Switzerland | ||||
| NanoSomiX | Formerly VC-backed | Aliso Viejo, CA |
StemCells Patents
StemCells Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20030032184-A1 | Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders | Active | 22-Jun-2001 | ||
| US-7211404-B2 | Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders | Inactive | 22-Jun-2001 | ||
| AU-2001250966-A1 | Pluripotential stem cells | Inactive | 23-Mar-2000 | ||
| US-20010049139-A1 | Transplantation of hematopoietic stem cells to repopulate functional hepatocytes; in vitro cell culture of regenerating hepatocytes generated from a human cell population; screening for genetic sequences using hybridization of an rna probe | Inactive | 23-Mar-2000 | ||
| EP-1227823-A2 | Methods for inducing (in vivo) proliferation and migration of transplanted progenitor cells in the brain | Inactive | 20-Oct-1999 | A61K35/30 |
StemCells Signals
StemCells Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
StemCells Investments & Acquisitions (2)
StemCells’s most recent deal was a Reverse Merger with Microbot Medical. The deal was made on 28-Nov-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Microbot Medical | 28-Nov-2016 | Reverse Merger | Other Healthcare Technology Systems | ||
| Cognetix | 01-Jul-1997 | Corporate | Connectivity Products |
StemCells Exits (1)
StemCells’s most recent exit was on 01-Jul-1997 from Cognetix. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Cognetix | 01-Jul-1997 | Completed |
|
StemCells FAQs
-
When was StemCells founded?
StemCells was founded in 1988.
-
Where is StemCells headquartered?
StemCells is headquartered in Newark, CA.
-
What is the size of StemCells?
StemCells has 50 total employees.
-
What industry is StemCells in?
StemCells’s primary industry is Biotechnology.
-
Is StemCells a private or public company?
StemCells is a Private company.
-
What is StemCells’s current revenue?
The current revenue for StemCells is .
-
How much funding has StemCells raised over time?
StemCells has raised $74.9M.
-
Who are StemCells’s investors?
CytoTherapuetics and The Vanguard Group have invested in StemCells.
-
Who are StemCells’s competitors?
Verge Labs, TauRx Pharmaceuticals, Neurogene, Asceneuron, and NanoSomiX are some of the 25 competitors of StemCells.
-
When was StemCells acquired?
StemCells was acquired on 28-Nov-2016.
-
Who acquired StemCells?
StemCells was acquired by Microbot Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process